Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study.

Tanya Babich, Pontus Naucler, John Karlsson Valik, Christian G Giske, Natividad Benito, Ruben Cardona, Alba Rivera, Celine Pulcini, Manal Abdel Fattah, Justine Haquin, Alasdair MacGowan, Sally Grier, Bibiana Chazan, Anna Yanovskay, Ronen Ben Ami, Michal Landes, Lior Nesher, Adi Zaidman-Shimshovitz, Kate McCarthy, David L PatersonEvelina Tacconelli, Michael Buhl (Co-author), Susanna Maurer, Jesus Rodriguez-Bano, Isabel Morales, Antonio Oliver, Enrique Ruiz de Gopegui, Angela Cano, Isabel Machuca, Monica Gozalo-Marguello, Luis Martinez-Martinez, Eva M Gonzalez-Barbera, Iris Gomez Alfaro, Miguel Salavert, Bojana Beovic, Andreja Saje, Manica Mueller-Premru, Leonardo Pagani, Virginie Vitrat, Diamantis Kofteridis, Maria Zacharioudaki, Sofia Maraki, Yulia Weissman, Mical Paul, Yaakov Dickstein, Leonard Leibovici, Dafna Yahav

    Research output: Contribution to journalOriginal Articlepeer-review

    40 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)105847
    JournalINTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    Volume55
    Issue number2
    DOIs
    Publication statusPublished - 2020

    Keywords

    • BLOOD-STREAM INFECTIONS
    • CLINICAL CHARACTERISTICS
    • STAPHYLOCOCCUS-AUREUS
    • ANTIMICROBIAL THERAPY
    • 30-DAY MORTALITY
    • IMPACT
    • EPIDEMIOLOGY

    Cite this